AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Apixaban 2.5mg
3 registrations across 3 African markets— 3 active
Markets with Apixaban 2.5mg
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Empixa 2.5 Film-Coated Tablet | 🇰🇪Kenya | Emcure Pharmaceuticals Limited | active | Apr 2030 |
| XABITOR 2.5MG TABLETS (Each film coated tablet contains apixaban 5mg | 🇬🇭Ghana | — | active | Jul 2029 |
| SUPIXA-2.5 Film Coated Tablets | 🇷🇼Rwanda | MICRO LABS LIMITED, | active | May 2029 |
Apixaban 2.5mg in Africa — Regulatory Overview
Apixaban 2.5mg is registered across 3 African markets with 3 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Kenya, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 3 registrations, 3 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.